Phil Melia, Corporate Tax Partner, and Max Stanyard, Innovation Reliefs Specialist, examine the impact of R&D regime changes for life sciences and biotech businesses in the UK.
This is the first of RSM’s videos focusing on key issues and opportunities for life sciences businesses.